Columbia Financial, Inc. CLBK ← Back to all reports

Columbia Financial, Inc.

CLBK · Financials
B ★★★ Hold
Aug 25, 2026 · Score 82 · Type A — Value-style analysis Used for established, cash-generative companies — weighs earnings power, valuation against the company's own history and peers, and margin of safety. Full methodology →
Current PriceThe market price around the time this report was written — not a live quote. The market has moved since; check a current price before acting.Methodology → $11.79
Buy ZoneThe large figure is the midpoint of the suggested buy range shown in parentheses. $10.50 ($10.25–$10.75)
Price TargetOur estimated fair value. For richly valued stocks it can sit below the current price — see Methodology.Methodology → $14.00
Expected Return
  • Target relative to the Current Price ((Target − Current) ÷ Current). Since that price is from the report date, your actual return will differ.
  • A negative figure isn't an error. For richly valued stocks, the fair-value target can sit below the current price, so the return reads negative. The grade reflects company quality; this figure reflects today's entry valuation.
Methodology →
+18.7%

Type A - Columbia Financial, Inc. (CLBK) 20260825 Stock Analysis

📅 Columbia Key Upcoming Events

🏢 Step 1: Columbia Company Overview & Business Model

Q1-A1. What is Columbia?

Q1-A2. How Does Columbia Make Money?

Q1-A3. Columbia’s Revenue Segments & Core Income Sources

Q1-A4. Who Are Columbia’s Competitors?

Q1-A5. Columbia Key Events: Past 12 Months

Q1-A6. Step 1 Key Takeaways

🏰 Step 2: Columbia’s Economic Moat, Growth & Capital Allocation

Q2-A1. Does Columbia Have a Durable Economic Moat?

Q2-A2. Is Columbia’s Growth Sustainable?

Q2-A3. How Does Columbia Allocate Capital & Return Cash?

Q2-A4. Step 2 Key Takeaways

💰 Step 3: Is Columbia Profitable? Financial Health Analysis

Q3-A2. How Profitable Is Columbia? (Margins & ROIC)

Q3-A3. What Drives Columbia’s Returns? (ROIC Breakdown)

Q3-A4. Are Columbia’s Earnings High Quality?

Q3-A5. Is Columbia’s Balance Sheet Healthy? (Debt & Leverage)

Q3-A6. Step 3 Key Takeaways

🔎 Step 4: Columbia Forensic Accounting & Dilution Review

Q4-A1. Does Columbia Have Accounting Red Flags?

Q4-A2. Is Columbia Overspending? (Capex & Capital Cycle)

Q4-A3. How Sound Is Columbia’s Cash Flow?

Q4-A4. Is Columbia Diluting Shareholders?

Q4-A5. Data Integrity Check

Q4-A6. Step 4 Key Takeaways

👔 Step 5: Columbia Management & Shareholder Alignment

Q5-A1. Can You Trust Columbia’s Management? (Guidance Track Record)

Q5-A2. What Are Columbia Insiders Doing?

Q5-A3. Is Columbia’s Management Aligned With Shareholders?

Q5-A4. Step 5 Key Takeaways

⛵ Step 6: Columbia Market Flow & Sentiment

Q6-A1. Analyst Consensus vs Columbia Guidance

Q6-A2. What Is Columbia’s Short Interest?

Q6-A3. Step 6 Key Takeaways

🚀 Step 7: Columbia Catalysts & Price Triggers

Q7-A1. What Could Move Columbia Stock? (Top 3 Catalysts)

Q7-A2. Columbia’s Earnings Revision Trend

Q7-A3. Step 7 Key Takeaways

⚖️ Step 8: Is Columbia Fairly Valued? Valuation Analysis

Q8-A1. Columbia’s Key Valuation Multiples (P/E, EV/EBITDA)

Q8-A2. Columbia vs Peers: Valuation Comparison

Q8-A3. Is Columbia Cheap or Expensive vs Its History?

Q8-A4-1. What Growth Hurdle Does the Market Demand From Columbia? (Reverse DCF Alternative)

Q8-A5. Valuation Cross-Check

Q8-A6. Columbia’s Hidden Asset & Stake Valuation

Q8-A7. Final Valuation Adjustment

Q8-A8. Valuation Adjustment Score Calculation

💀 Step 9: What Are the Risks of Columbia? Fatal Risks & Pre-Mortem

Q9-A1. What Are the Biggest Risks to Columbia?

Q9-A2. How Sensitive Is Columbia to the Economy?

Q9-A3. Columbia Pre-Mortem: What Could Go Wrong?

Q9-A4. Risk Adjustment Score

🎯 Step 10: Columbia Final Verdict: Score & Rating

Q10-A1. Investment Score & Rating

Q10-A2. Should You Buy Columbia? (Recommendation)

Q10-A3. Investment Thesis in One Line

Q10-A4. Columbia’s Price Trend & Key Drivers

Q10-A5. Action Plan

🕵️‍♂️ Deep Dive Analysis

Q1: Is Columbia’s Heavy Exposure to Rent-Regulated Multifamily Loans Its Biggest Weakness?

Q2: Can Columbia’s 21x Forward P/E Be Justified by the Anticipated 50% EPS Accretion in 2027?

Q3: Will the Integration of Northfield Bancorp Derail Columbia’s Operational Efficiency?

Q4: How Will the Mandatory One-Year Buyback Moratorium Impact Columbia’s Share Price Velocity?

Q5: Can Columbia Sustain Its Explosive 25 Basis Point NIM Expansion Through 2027?

Q6: Does Columbia’s 1.70% Dividend Yield Offer Enough Protection for Defensive Investors?

Q7: Will the Influx of Institutional Index Buyers Provide a Structural Floor for Columbia’s Stock?

Q8: Is the 16.4% Tangible Common Equity Ratio Actually Inefficient Capital Management?

Q9: How Vulnerable Is Columbia to a Resurgence in Commercial Deposit Flight?

Q10: Does Columbia Possess the Technological Infrastructure to Compete With Megabanks in NY/NJ?